Dynamic Choice HIV Prevention Intervention at Outpatient Departments in Rural Kenya and Uganda
Overview
Authors
Affiliations
Objective: HIV prevention service delivery models that offer product choices, and the option to change preferences over time, may increase prevention coverage. Outpatient departments in sub-Saharan Africa diagnose a high proportion of new HIV infections, but are an understudied entry point to biomedical prevention.
Design: Individually randomized trial of dynamic choice HIV prevention (DCP) intervention vs. standard-of-care (SOC) among individuals with current/anticipated HIV exposure risk at outpatient departments in rural Kenya and Uganda (SEARCH; NCT04810650).
Methods: Our DCP intervention included 1) product choice (oral preexposure prophylaxis [PrEP] or postexposure prophylaxis [PEP]) with an option to switch over time, 2) HIV provider- or self-testing, 3) service location choice (community vs. clinic-based), and 4) provider training on patient-centered care. Primary outcome was proportion of follow-up covered by PrEP/PEP over 48 weeks assessed via self-report.
Results: We enrolled 403 participants (61% women; median 27 years, IQR 22-37). In the DCP arm, 86% ever chose PrEP, 15% ever chose PEP over 48 weeks; selection of HIV self-testing increased from 26 to 51% and of out-of-facility visits from 8 to 52%. Among 376 of 403 (93%) with outcomes ascertained, time covered by PrEP/PEP was higher in DCP (47.5%) vs. SOC (18.3%); difference = 29.2% (95% confidence interval: 22.7-35.7; P < 0.001). Effects were similar among women and men (28.2 and 31.0% higher coverage in DCP, respectively) and larger during periods of self-reported HIV risk (DCP 64.9% vs. SOC 26.3%; difference = 38.6%; 95% confidence interval: 31.0-46.2; P < 0.001).
Conclusion: A dynamic choice HIV prevention intervention resulted in two-fold greater time covered by biomedical prevention products compared to SOC in general outpatient departments in eastern Africa.
Preventing HIV in women in Africa.
Cowan F, Shahmanesh M, Revill P, Busza J, Sibanda E, Chabata S Nat Med. 2025; .
PMID: 39948405 DOI: 10.1038/s41591-025-03535-8.
Bassett I, Yan J, Govere S, Shezi S, Ngcobo L, Sagar S BMC Public Health. 2025; 25(1):524.
PMID: 39922997 PMC: 11806743. DOI: 10.1186/s12889-025-21718-3.
Kamya M, Balzer L, Ayieko J, Kabami J, Kakande E, Chamie G Lancet HIV. 2024; 11(11):e736-e745.
PMID: 39395424 PMC: 11753513. DOI: 10.1016/S2352-3018(24)00235-2.
McGuire C, Atieno M, Hoke T, Jeckonia P, Korimba K, Lorenzetti L Curr HIV/AIDS Rep. 2024; 21(5):282-292.
PMID: 39046639 PMC: 11377463. DOI: 10.1007/s11904-024-00704-1.